Marsh & McLennan (MMC) Tops Q2 EPS by 19c
- Apple, healthcare stocks lift S&P 500 amid Delta variant worries
- Tencent (TCEHY) Falls Sharply as State Media Describes Online Games as ‘Spiritual Opium’, Company Vows to Improve
- Oil extends losses in volatile trade as Delta variant angst spreads
- Clorox (CLX) Falls Sharply as COVID-19 Demand Wanes
- Dollar languishes, other safe haven currencies shine amid Delta caution
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Marsh & McLennan (NYSE: MMC) reported Q2 EPS of $1.32, $0.19 better than the analyst estimate of $1.13. Revenue for the quarter came in at $4.19 billion versus the consensus estimate of $4.19 billion.
- Second Quarter Operating Income Rises 30% and Adjusted Operating Income Increases 10%
- Second Quarter EPS Rises to $1.12 from $0.65 and Adjusted EPS Increases 12% to $1.32
- Six Months Operating Income Rises 21% and Adjusted Operating Income Increases 13%
- Six Months EPS Rises to $2.60 from $2.05 and Adjusted EPS Increases 10% to $2.96
Dan Glaser, President and CEO, said: “In the midst of the pandemic, we delivered another strong quarter reflecting outstanding execution and the resilience of our business. In the second quarter, despite a modest decline in underlying revenue due to the global impact of COVID-19, we generated 10% adjusted operating income growth and 12% growth in adjusted EPS. For the first six months of 2020, we achieved 2% underlying revenue growth and 10% adjusted EPS growth.
"I am humbled by our colleagues’ exceptional support of our clients and one another during these tumultuous times.”
For earnings history and earnings-related data on Marsh & McLennan (MMC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Applied DNA Sciences (APDN) Awarded The City University of New York (CUNY) COVID-19 Testing Contract
- Nikola (NKLA) Tops Q2 EPS by 9c
- Heska (HSKA) Tops Q2 EPS by 71c
Create E-mail Alert Related CategoriesCorporate News, Earnings, Management Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!